Department of Anesthesia and Critical Care, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University.
Department of Biochemistry, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou.
Rheumatology (Oxford). 2022 Nov 2;61(11):4521-4534. doi: 10.1093/rheumatology/keac069.
Over-proliferation of synovium is a key event of invasive pannus formation and cartilage damage in the progression of RA disease. At the same time, ferroptosis may play a pivotal role in maintaining the balance of proliferation and death of synovium. In this study, we firstly evaluated the ferroptosis level in RA fibroblast-like synoviocytes (FLS) and then explored the role of glycine in ferroptosis.
Ferroptosis was evaluated in RA synovium and FLS. The therapeutic effect of glycine on RA was evaluated by clinical and histopathological score and cytokine level in a CIA mouse model. The influence of glycine on ferroptosis was evaluated by mitochondrial morphology observation and membrane potential assay in RA FLS. Methylase expression was detected to explore the mechanism behind the effect of glycine on glutathione peroxidase 4 (GPX4) methylation.
Compared with healthy controls, ferroptosis decreased in the RA synovium and FLS, with a decrease in Acyl Coenzyme A Synthetase Long Chain 4 (ACSL4) and an increase in Ferritin heavy chain 1 (FTH1), GPX4 and cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11). Although both oxidation and antioxidation levels of lipids were higher in RA FLS than in healthy controls, the increase in antioxidation was slightly higher than oxidation. RNA-seq and verification showed that glycine regulated the ferroptosis pathway through increase S-adenosylmethionine (SAM) concentration and decrease the expression of GPX4 and FTH1 by promoting SAM-mediated GPX4 promoter methylation and reducing FTH1 expression in RA FLS.
In summary, we confirmed a decline in ferroptosis in RA and explored that glycine enhanced ferroptosis via SAM-mediated GPX4 promoter methylation and ferritin decrease.
滑膜细胞过度增生是类风湿关节炎(RA)疾病进展中侵袭性血管翳形成和软骨损伤的关键事件。同时,铁死亡可能在维持滑膜细胞增殖和死亡的平衡中发挥关键作用。在本研究中,我们首先评估了 RA 成纤维样滑膜细胞(FLS)中的铁死亡水平,然后探讨了甘氨酸在铁死亡中的作用。
评估 RA 滑膜和 FLS 中的铁死亡。通过 CIA 小鼠模型的临床和组织病理学评分以及细胞因子水平评估甘氨酸对 RA 的治疗作用。通过观察线粒体形态和膜电位测定评估甘氨酸对 RA FLS 中铁死亡的影响。检测甲基转移酶表达,以探讨甘氨酸对谷胱甘肽过氧化物酶 4(GPX4)甲基化影响的机制。
与健康对照组相比,RA 滑膜和 FLS 中的铁死亡减少,酰基辅酶 A 合成酶长链 4(ACSL4)减少,铁蛋白重链 1(FTH1)、GPX4 和胱氨酸/谷氨酸反向转运体溶质载体家族 7 成员 11(SLC7A11)增加。尽管 RA FLS 中的脂质氧化和抗氧化水平均高于健康对照组,但抗氧化水平的升高略高于氧化水平。RNA-seq 和验证表明,甘氨酸通过促进 S-腺苷甲硫氨酸(SAM)浓度增加和降低 GPX4 和 FTH1 的表达,通过促进 SAM 介导的 GPX4 启动子甲基化和减少 RA FLS 中的 FTH1 表达,调节铁死亡途径。
综上所述,我们证实了 RA 中铁死亡的下降,并探讨了甘氨酸通过 SAM 介导的 GPX4 启动子甲基化和铁蛋白减少增强铁死亡的机制。